UK markets close in 7 hours 35 minutes
  • FTSE 100

    7,509.86
    +8.97 (+0.12%)
     
  • FTSE 250

    20,350.00
    +11.04 (+0.05%)
     
  • AIM

    934.73
    +1.53 (+0.16%)
     
  • GBP/EUR

    1.1825
    +0.0005 (+0.04%)
     
  • GBP/USD

    1.2102
    -0.0037 (-0.30%)
     
  • BTC-GBP

    19,872.25
    -840.20 (-4.06%)
     
  • CMC Crypto 200

    571.52
    +0.24 (+0.04%)
     
  • S&P 500

    4,280.15
    +72.88 (+1.73%)
     
  • DOW

    33,761.05
    +424.35 (+1.27%)
     
  • CRUDE OIL

    90.50
    -1.59 (-1.73%)
     
  • GOLD FUTURES

    1,802.80
    -12.70 (-0.70%)
     
  • NIKKEI 225

    28,871.78
    +324.80 (+1.14%)
     
  • HANG SENG

    20,036.03
    -139.59 (-0.69%)
     
  • DAX

    13,779.45
    -16.40 (-0.12%)
     
  • CAC 40

    6,551.57
    -2.29 (-0.03%)
     

Global Polymer Biomaterial Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F - ResearchAndMarkets.com

·4-min read

DUBLIN, November 29, 2021--(BUSINESS WIRE)--The "Polymer Biomaterial Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

The global polymer biomaterial market is expected to grow from $47.05 billion in 2020 to $53.87 billion in 2021 at a compound annual growth rate (CAGR) of 14.5%. The market is expected to reach $93.98 billion in 2025 at a CAGR of 15%.

Major players in the polymer biomaterial market are BASF, Corbion, Zimmer Biomet, Royal DSM, Koninklijke DSM, Covestro, Evonik Industries, Starch Medical, Victrex, and W. L. Gore & Associate.

The polymer biomaterial market consists of sales of polymer biomaterial and related services by entities (organizations, sole traders and partnerships) that produce polymer biomaterial used for enhancing the functionality of tissues and organs that are damaged in various disease therapies. Polymer biomaterials are inert pharmacological substances made up of natural and synthetic origin.

The polymer biomaterial market covered in this report is segmented by type into nylon, silicone rubber, polyester, polymethyl methacrylate (PMMA), polyethylene (PE), polyvinyl chloride, others and by application into cardiovascular, ophthalmology, dental, plastic surgery, wound healing, tissue engineering, orthopedics, neurological disorders/central nervous system, others.

Stringent regulatory systems concerning the biocompatibility of the polymer biomaterials is expected to limit the global polymer biomaterials market. Although biomaterials undergo rigorous premarket evaluations, considerable adverse events and complications are reported regarding the biocompatibility of polymer biomaterials.

Biomaterial implantation may result in immunological and inflammatory reactions due to the induction of cellular and molecular events in the host, which may lead to excessive inflammation, impairment of healing, fibrotic encapsulation, tissue destruction, or even isolation and rejection of the implant. To overcome such adverse immune reactions, stringent regulations are imposed by the regulatory authorities, restricting market growth.

Companies in the polymer biomaterial market are increasingly investing in bioresorbable copolymers for medical devices for better performance and long-term stability. Companies such as Evonik have invested in bioresorbable polymers for use in implantable medical devices.

The company's copolymer possesses hydrophobic properties of polylactide and hydrophilic properties of polyethylene glycol enabling the degradation rates up to six times faster with added mechanical strength. This innovation enhances biocompatibility, safety and performance of implantable products, and is applied in the areas of pediatrics and wound closure to accelerate and ease the healing process and provides long term stability.

Increasing applications of polymeric biomaterials in tissue engineering are driving the global polymer biomaterials market. Polymers are extensively used in regenerative medicine and tissue engineering due to their flexibility and versatile properties such as tailoring the damaged tissue's physical, chemical and mechanical properties by modification of functional groups during synthesis, according to the regeneration capability of tissues of the organs.

Besides being biodegradable, they offer different geometry and structures, thus meeting the needs of specific tissue engineering applications. These growing applications of polymer biomaterial in tissue engineering are expected to drive the market in the forecast period.

Key Topics Covered:

1. Executive Summary

2. Polymer Biomaterial Market Characteristics

3. Polymer Biomaterial Market Trends and Strategies

4. Impact Of COVID-19 On Polymer Biomaterial

5. Polymer Biomaterial Market Size and Growth

5.1. Global Polymer Biomaterial Historic Market, 2015-2020, $ Billion

5.1.1. Drivers Of the Market

5.1.2. Restraints On the Market

5.2. Global Polymer Biomaterial Forecast Market, 2020-2025F, 2030F, $ Billion

5.2.1. Drivers Of the Market

5.2.2. Restraints On the Market

6. Polymer Biomaterial Market Segmentation

6.1. Global Polymer Biomaterial Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Nylon

  • Silicone Rubber

  • Polyester

  • Polymethyl Methacrylate (PMMA)

  • Polyethylene (PE)

  • Polyvinyl Chloride

  • Others

6.2. Global Polymer Biomaterial Market, Segmentation by Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Cardiovascular

  • Ophthalmology

  • Dental

  • Plastic Surgery

  • Wound Healing

  • Tissue Engineering

  • Orthopedics

  • Neurological Disorders / Central Nervous System

  • Others

6.3. Global Polymer Biomaterial Market, Segmentation by Nature, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

  • Natural

  • Synthetic

7. Polymer Biomaterial Market Regional and Country Analysis

7.1. Global Polymer Biomaterial Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

7.2. Global Polymer Biomaterial Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Companies Mentioned

  • BASF

  • Corbion

  • Zimmer Biomet

  • Royal DSM

  • Koninklijke DSM

  • Covestro

  • Evonik Industries

  • Starch Medical

  • Victrex

  • W. L. Gore and Associate

  • Bayer

  • DSM Biomedical

  • Purac Biomaterials

  • Ticona

  • Invibo

  • Covalon Technologies

  • Osteotech

  • Medtronic

  • Stryker Corporation

  • Synthes

  • Mitsui

  • Polyfibre Industries

  • Toray Industries

  • Stein Fibers

  • Diyou Fiber

  • Silon

  • Swicofil

  • Green Fiber International

  • Reliance Industries

For more information about this report visit https://www.researchandmarkets.com/r/oowxlw

View source version on businesswire.com: https://www.businesswire.com/news/home/20211129005603/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting